Zobrazeno 1 - 10
of 11
pro vyhledávání: '"David Hastie"'
Autor:
David Hastie
Publikováno v:
Journal of Religious History.
Autor:
David Hastie
Publikováno v:
Reformation. 26:146-154
Autor:
Jason Cohen, David Uihwan Lee, Gregory Fan, David Hastie, Akaash Mittal, Khanh Le, Yeeun Jang, Sarav Daid, Raffi Karagozian, Raza Malik
Publikováno v:
Journal of Hepatology. 77:S203-S204
Autor:
David Uihwan Lee, Jason Cohen, Gregory Fan, David Hastie, Akaash Mittal, Khanh Le, Yeeun Jang, Sarav Daid, Raffi Karagozian, Raza Malik
Publikováno v:
Journal of Hepatology. 77:S204
Autor:
Jason Cohen, David U. Lee, Gregory H. Fan, David Hastie, Akaash Mittal, Khanh Le, Yeeun Jang, Sarav Daid, Raffi Karagozian, Raza Malik
Publikováno v:
Gastroenterology. 162:S-1280
Autor:
David U. Lee, Jason Cohen, Gregory H. Fan, David Hastie, Akaash Mittal, Khanh Le, Yeeun Jang, Sarav Daid, Raffi Karagozian, Raza Malik
Publikováno v:
Gastroenterology. 162:S-1279
Autor:
Mikael L. Rinne, Patrick Y. Wen, David A. Reardon, Prashin Unadkat, Lais Cabrera, Sylvia Kurz, Lakshmi Nayak, Eudocia Q. Lee, David Hastie, Raymond Y. Huang
Publikováno v:
Neurology. 91:e1355-e1359
ObjectiveTo investigate the question of whether salvage therapy with the programmed cell death protein 1 (PD-1)–blocking antibodies nivolumab or pembrolizumab with or without bevacizumab offers clinical or survival benefit in patients with recurren
Autor:
David Hastie
Publikováno v:
Journal of Christian Education. :17-33
This paper offers a response to the new Australian English Curriculum, by focusing on the idea of literature in transition from the current syllabi into the new, particularly regarding the concerns of faith-based schooling. The recent history of Engl
Autor:
Bruce David Hastie
Publikováno v:
Journal of Oncology Pharmacy Practice. 1:23-31
Background. Following the introduction of the 5HT3 (serotonin) receptor antagonists into New Zea land we wished to determine the current role that these and other antiemetic agents have in the preven tion and treatment of nausea and vomiting in oncol